APA (7th ed.) Citation

YN, K., A, M., R, M., I, B., A, K., I, B., . . . S, B. (2026). Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: Stewardship implications. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05701-2

Chicago Style (17th ed.) Citation

YN, Khan, Mala A, Murtaza R, Batool I, Khan A, Begum I, Muqtadir J, Rasheed A, and Bhatti S. "Outcomes of Linezolid, Glycopeptides, and Other Regimens in Ampicillin-resistant, Vancomycin-susceptible and Vancomycin-resistant Enterococcal Bacteremia in a Resource-limited Setting: Stewardship Implications." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05701-2.

MLA (9th ed.) Citation

YN, Khan, et al. "Outcomes of Linezolid, Glycopeptides, and Other Regimens in Ampicillin-resistant, Vancomycin-susceptible and Vancomycin-resistant Enterococcal Bacteremia in a Resource-limited Setting: Stewardship Implications." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05701-2.